Dresske, Bettina <br/><br/>
WOFIE synergizes with calcineurin-inhibitor treatment and early steroid withdrawal in kidney transplantation.  [electronic resource] 

 -  Transplantation  Apr 2003 
 - 1286-91 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>0041-1337 
<br/><br/><label>Standard No.: </label>10.1097/01.TP.0000061791.71792.79  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Acute Disease<br/>Adult<br/>Aged<br/>Antibodies, Monoclonal--administration & dosage<br/>Antibodies, Monoclonal, Humanized<br/>Calcineurin Inhibitors<br/>Daclizumab<br/>Drug Administration Schedule<br/>Female<br/>Glucocorticoids--administration & dosage<br/>Graft Rejection--epidemiology<br/>Graft Survival--drug effects<br/>Humans<br/>Immunoglobulin G--administration & dosage<br/>Immunosuppressive Agents--administration & dosage<br/>Incidence<br/>Kidney--physiopathology<br/>Kidney Transplantation<br/>Male<br/>Middle Aged<br/>Prednisolone--administration & dosage<br/>Survival Analysis<br/>Tacrolimus--administration & dosage